NOVEMBER 15, 2004
VOLUME 1 NO. 21
 

Corticosteroids cut down on cardiac concerns in COPD


Environmental activist Chris Hobbs, 57, fights for clean air so others can breathe easy, though chronic obstructive pulmonary disease (COPD) makes breathing tough for him. Unfortunately, his rhetoric isn't the only inflammatory thing around. His elevated serum levels of C-reactive protein (CRP) are a sign of lung inflammation, which in turn is linked to cardiovascular problems, and even death, in COPD patients. The good news is that Canadian researchers reported in the October 1 issue of the American Journal of Respiratory and Critical Care Medicine that fluticasone and prednisone reduce CRP in COPD patients.

Dr Paul Man, of Vancouver's St Paul's Hospital, and his colleagues had 41 patients with mild to moderate COPD prepare for the study � la Bill Clinton, by abjuring drug inhalation for four weeks, although corticosteroids, not marijuana, were involved. As patients' corticosteroid levels fell, CRP levels increased by 71%.

For the subsequent two weeks, patients inhaled fluticasone, gulped prednisone or took a placebo. In the fluticasone crowd, CRP levels dropped back by 50%, while those treated with oral prednisone fared even better with a 63% drop. The placebo group had no significant drop in CRP.

During the next 16 weeks, all patients inhaled fluticasone. After eight weeks, CRP levels were lower than before the initial four-week corticosteroid-free period. This suggests that oral and inhaled corticosteroids have cardio-protective effects in COPD patients.

"The use of inhaled corticosteroids in COPD is controversial. We are of the opinion, on the basis of our own studies and those of others, that [inhaled cortocosteroid] is beneficial," said Dr Man. "Not all the experts in the area endorse such practice." Indeed, these encouraging results require bigger studies before their real significance is apparent. But, for now, reduced systemic inflammation resulting from corticosteroid use "raise[s] the possibility that [corticosteroids] could have salutary effects on cardiovascular morbidity and mortality in COPD," said Dr Man.

 

 

back to top of page

 

 

 

 
 
© Parkhurst Publishing Privacy Statement
Legal Terms of Use
Site created by Spin Design T.